World's Best Scientists 2026 revealed!
Anne J. Novak

Anne J. Novak

D-Index & Metrics

Immunology

D-Index
60
Citations
14326
World Ranking
3312
National Ranking
1540

Anne J. Novak publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Anne J. Novak sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 333 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Anne J. Novak D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Anne J. Novak sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 60 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Best Publications

  • Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

    Bjoern Chapuy;Chip Stewart;Andrew J Dunford;Jaegil Kim

  • Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival.

    Anne J. Novak;Anne J. Novak;Jaime R. Darce;Jaime R. Darce;Bonnie K. Arendt;Bonnie K. Arendt;Brandon Harder;Brandon Harder

  • Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma

    Zhi Zhang Yang;Anne J. Novak;Mary J. Stenson;Thomas E. Witzig

  • An APRIL to remember: novel TNF ligands as therapeutic targets

    Stacey R. Dillon;Jane A. Gross;Stephen M. Ansell;Anne J. Novak

  • IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma

    Zhi Zhang Yang;Deanna M. Grote;Steven C. Ziesmer;Toshiro Niki

  • Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival.

    Anne J. Novak;Richard J. Bram;Neil E. Kay;Diane F. Jelinek

  • Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.

    Anne J. Novak;Deanna M. Grote;Mary Stenson;Steven C. Ziesmer

  • CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intratumoral CD4+CD25 T cells.

    Zhi Zhang Yang;Anne J. Novak;Steven C. Ziesmer;Thomas E. Witzig

  • B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders.

    Ryan A. Wilcox;Andrew L. Feldman;David A. Wada;Zhi Zhang Yang

  • Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma.

    Zhi Zhang Yang;Anne J. Novak;Steven C. Ziesmer;Thomas E. Witzig

  • Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

    Sonja I. Berndt;Christine F. Skibola;Christine F. Skibola;Vijai Joseph;Nicola J. Camp

  • Expression of LAG-3 defines exhaustion of intratumoral PD-1 + T cells and correlates with poor outcome in follicular lymphoma

    Zhi Zhang Yang;Hyo Jin Kim;Jose C. Villasboas;Ya Ping Chen

  • Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas.

    A L Feldman;D X Sun;M E Law;A J Novak

  • Proteomic analysis of mantle-cell lymphoma by protein microarray.

    Irene M. Ghobrial;Daniel J. McCormick;Scott H. Kaufmann;Alexey A. Leontovich

  • Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin's lymphoma.

    Zhi Zhang Yang;Anne J. Novak;Steven C. Ziesmer;Thomas E. Witzig

  • Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.

    James R. Cerhan;Sonja I. Berndt;Joseph Vijai;Hervé Ghesquières

  • Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2

    Mamta Gupta;Stephen M. Ansell;Anne J. Novak;Shaji Kumar

  • Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells

    Ryan A. Wilcox;David A. Wada;Steven C. Ziesmer;Sherine F. Elsawa

  • Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma.

    Zhi Zhang Yang;Deanna M. Grote;Steven C. Ziesmer;Michelle K. Manske

  • PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival

    Z Z Yang;D M Grote;S C Ziesmer;B Xiu

Frequent Co-Authors

Thomas E. Witzig
Thomas E. Witzig Mayo Clinic
James R. Cerhan
James R. Cerhan Mayo Clinic
Susan L. Slager
Susan L. Slager Mayo Clinic
Ahmet Dogan
Ahmet Dogan Memorial Sloan Kettering Cancer Center
Yan W. Asmann
Yan W. Asmann Mayo Clinic
Hans-Olov Adami
Hans-Olov Adami Karolinska Institute
Angela Brooks-Wilson
Angela Brooks-Wilson Simon Fraser University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Anne J. Novak

Recently Published Articles